(Q44563592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

2,6,8,9-tetrasubstituted purines as new CDK1 inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

René Lenobel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Michal Otyepka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Jiří Moravec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

10

Miroslav Strnad

1 reference

7 November 2019

Jan Hanus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Libor Havlícek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Daniela Moravcová

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kvetoslava Fuksová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Marek Kuzma

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

2993-2996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in cyclin-dependent kinase inhibition. Purine-based derivatives as anti-cancer agents. Roles and perspectives for the future

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Synthesis and biological activity of olomoucine II.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

The design and synthesis of purine inhibitors of CDK2. III.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

A p34(cdc2) survival checkpoint in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Docking-Based Development of Purine-like Inhibitors of Cyclin-Dependent Kinase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900632-2

7 January 2021

10.1016/S0960-894X(03)00632-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12941319%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference